Biofrontera Inc. (NASDAQ: BFRI) has recently released its quarterly financial results for the period ending March 31, 2025, showing both progress in revenue generation and ongoing challenges impacting its operational continuity.
Positive Aspects:
Revenue Growth: Total revenues increased to $8.58...